Deloitte and Vineti announced that they are now working together to integrate and scale their technology platforms – for supply chain and patient engagement, respectively – to give various precision medicine stakeholders easier access to emerging cellular therapies.
from News from healthcareitnews.com https://ift.tt/2NK2Zu4
Thursday, September 6, 2018
RELATED STORIES
Healthcare organizations turning to wide range of vendors in pandemicPerhaps unsurprisingly, a new KLAS report finds t- HITN APAC eBook: Dealing with the COVID-19 outbreak through digital health in APACThe upcoming eBook will be launched on 12 May.&nb
- Hong Kong’s Public Sector Trial Scheme calls for projects to combat COVID-19On March 9, the Innovation and Technology Commiss
- HIT-related developments in APAC – A 2019 OverviewA broad look of HIT-related developments in the A
- Medtronic to acquire the French implant tech company MedicreaMedtronic says the acquisition means it will be a
- Remote patient monitoring can help address the maternal mortality crisisFran Ayalasomayajula, founder and president of Re
0 comments: